Resistance May Be Pharmacy's Best Bet In Meningitis Probe

Law360, New York (October 24, 2012, 10:41 PM EDT) -- Counsel for the New England Compounding Center has criticized and even directed blame toward regulators in the wake of a deadly meningitis outbreak, a tactic attorneys say would make little sense for a more established drugmaker but could offer the best strategy for a pharmacy likely on the verge of insolvency.

The NECC's attorney Paul Cirel of Collora LLP has now issued statements in consecutive weeks chastising government regulators. Last week, following a raid of the NECC's Framingham, Mass., facility by the U.S. Food and Drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.